Autoantibodies to a novel early endosome antigen 1

Clinical Immunology and Immunopathology

Volumn 86, Issue 1, 1998, Pages 81-87

  Waite, Rochelle L ^a   Sentry, John W ^a   Stenmark, Harald ^b   Toh, Ban Hock ^a  

^a ALFRED HOSPITAL   (Australia)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autoantibodies; Autoimmune disease; Early endosome antigen 1 (EEA1); Polyarticular disease; Subacute cutaneous lupus erythematosus

Indexed keywords

AUTOANTIBODY; CELL ANTIGEN; IMMUNOGLOBULIN G1;

ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSOME; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031983762     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4455     Document Type: Article

References (22)

1. Tan E. M. Antinuclear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44:1989;93-151.
2. Yeo J. P., Toh B. H. Cell cycle-associated autoantibodies: Markers for autoimmunity and probes for molecular cell biology. Autoimmunity. 18:1994;291-300.
3. Toh B. H., Gleeson P. A., Simpson R. J., Moritz R. L., Callaghan J. M., Goldkorn I., Jones C. M., Martinelli T. M., Mu F. T., Humphris D. C. The 60- to 90-kDa parietal cell autoantigen associated with autoimmune gastritis is a beta subunit of the gastric H+/K(+)-ATPase (proton pump). Proc. Natl. Acad. Sci. USA. 87:1990;6418-6422.
4. Kooy J., Toh B. H., Gleeson P. A. Heterogeneity of human anti-Golgi auto-antibodies: Reactivity with components from 35-260 kDa. Immunol. Cell Biol. 72:1994;123-127.
5. Mu F. T., Callaghan J. M., Steele-Mortimer O., Stenmark H. S., Parton R. G., Campbell P. L., McCluskey J., Yeo J. P., Tock E. P. C., Toh B. H. EEA1, an early endosomal protein. J. Biol. Chem. 270:1995;13503-13511.
6. Erlich R., Gleeson P. A., Campbell P. L., Dietzsch E., Toh B. H. Molecular characterization oftrans. J. Biol. Chem. 271:1996;8328-8337.
7. Gitlits, V. Sentry, J. W. Matthew, M. Smith, A. I. Toh, B. H. Autoantibodies to enolase in a patient with discoid lupus erythematosus, Immunology.
8. Smolen J. S., Zielinski C. C. Systemic Lupus Erythematosus: Clinical and Experimental Aspects. 1987;Springer-Verlag, Berlin. p. 7-13.
9. Quismorio F. P. Jr. Clinical relevance of serologic abnormalities in SLE. Dubois' Lupus Erythematosus. 1992;Williams & Wilkins, Baltimore. p. 461-473.
10. Swaak A. J. G., Aarden L. A., Statius van Eps L. W., Feltkamp T. E. W. Anti-ds DNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 22:1979;226-235.
11. Gilliam J. N., Sontheimer R. D. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J. Am. Acad. Dermatol. 4:1981;471.
12. Stenmark H., Aasland R., Toh B. H., D'Arrigo D. Endosomal localisation of the autoantigen EEA1 is mediated by a zinc binding FYVE finger. J. Biol. Chem. 271:1996;24048-24054.
13. Gruenberg J., Maxfield F. R. Membrane transport in the endocytic pathway. Curr. Opin. Cell. Biol. 7:1995;552-562.
14. McCauliffe D. P., Sontheimer R. D. Subacute cutaneous lupus erythematosus. Wallace D. J., Hahan B. H. Dubois' Lupus Erythematosus. 1992;302-310 Williams & Wilkins, Baltimore.
15. Cohen S., Stastny P., Sontheimer R. D. Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 29:1986;421-425.
16. Boire G., Menard H. A. Clinical significance of anti-Ro (SSA) antibody in rheumatoid arthritis. J. Rheumatol. 15:1988;391-394.
17. Simon M., Girbal E., Sebbag M., Gomes-Daudrix V., Vincent C., Salama G., Serre G. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies" autoantibodies specific for rheumatoid arthritis. J. Clin. Invest. 2:1993;1387-1393.
18. Steiner G., Hartmuth K., Skriner K., Maurer-Fogy I., Sinki A., Thalman E., Hassfeld W., Barta A., Smolen J. S. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J. Clin. Invest. 90:1992;1061-1066.
19. Hoet R. M., Boerbooms A. M., Arends M., Ruiter D. J., van Venrooil W. J. Antiperinuclear factor, a marker for rheumatoid arthritis: Colocalisation of the perinuclear factor and profilaggrin. Ann. Rheum. Dis. 50:1991;611-618.
20. Depres N., Boire G., Lopez-Longo F. J., Menard H. A. The Sa system: A novel antigen-antibody system specific for rheumatoid arthritis. J. Rheum. 21:1994;1027-1033.
21. Depres N., Talbot G., Plouffe B., Boire G., Menard H. A. Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera. J. Clin. Invest. 95:1995;1891-1896.
22. Mimori T., Suganuma K., Tanami Y., Nojima T., Matsumura M., Fujii T., Yoshizawa T., Suzuki K., Akizuki M. Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases. Proc. Natl. Acad. Sci. USA. 92:1995;7267-7271.